Cot-IN-4
Cot-IN-4 (compound 32) is a potent cancer osaka thyroid (COT) kinase inhibitor with an IC50 of 6 nM. Cot-IN-4 inhibits the phosphorylation of ERK (IC50: 60 nM) and inhibits TNFα release (IC50: 60 nM) . Cot-IN-4 also inhibits the formation of the pro-inflammatory cytokine IL-1β (IC50: 0.2 μM) in Uric acid (HY-B2130) -stimulated macrophages. Cot-IN-4 can be used for the study of inflammatory diseases[1].
Product Specifications
CAS Number
[1984784-10-2]
UNSPSC
12352005
Target
ERK; Interleukin Related; MAP3K; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway; Stem Cell/Wnt
Field of Research
Inflammation/Immunology
Smiles
CC(CN1CCOCC1)NC2=CC=C3C(C=CC(N4C=NC5=C4C6=C(N=C5)C=NC(C7=CC=NC=C7)=C6)=C3)=N2
Molecular Formula
C30H28N8O
Molecular Weight
516.60
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERK; IL-1; MAP3K8/COT/Tpl2; TNFRSF5/CD40
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
FUT7 (Fucosyltransferase 7 (alpha (1,3) Fucosyltransferase), FucT-VII) (PE)
FUT7 (Fucosyltransferase 7 (alpha (1,3) Fucosyltransferase), FucT-VII) (PE)
Acetyl CoA Carboxylase 1 (ACAC, ACC, ACC1, ACCA, ACC-alpha, Acetyl-CoA carboxylase alpha) (MaxLight 750) discontinued
